Medication Adherence in Clinical Trials: A Conversation with Joanne Watters

Jessica Barone • September 30, 2022

Medication adherence, the therapeutic maintenance of medication by a patient, is an essential part of daily female health, but also an essential metric for quality data in pharmaceutical clinical trials. This week we had the pleasure of hearing from Joanne Watters, the managing Director at Information Mediary Corp. (IMC), about her experience in the medication adherence technology field. IMC is a leader in medication adherence smart solutions, particularly for clinical trials.  


IMC’s smart blister dose packaging and pill bottles are an emerging digital health technology that tracks medication adherence in both clinical trials and daily use. For medication-based treatment plans to be successful, therapeutic windows need to be adhered to. When not taken properly, medication will not adequality treat persistent health issues, which leads providers to utilize a trial-and-error approach. This often causes physical discomfort as well as can lead to miscommunication, which are some of the established key factors of non-adherence. With IMC’s adherence technology, providers and clinical trial sponsors can visualize trends and patterns that are useful for data collection and patient intervention. Through this effort, daily maintenance therapeutic dosing for medication could become a less burdensome task. In turn, this could help bridge the gap between healthcare providers and patients.   

In clinical trials where quality data can make or break drug approval, providers and drug sponsors can utilize this information to make improvements and confirm proper dosage amounts before obtaining FDA approval. Additionally, IMC’s technology provides data in real-time showcasing if treatment regimens are being completed successfully. Through this modality, providers as well as clinical trial sponsors can develop deeper insight into the practicalities of routines and whether there is sustainability in treatment algorithms. For maintenance of female health, this technology could help identify barriers for time sensitive dosing, such as fertility treatments, birth control, and even prenatal supplements. For more information on this topic, check out the recording of Joanne Watters’ conversation here:

Play Video

Explore Recent Posts